Skip to main content
Caplight Logo









Stablix

Stablix

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.stablix.com/

Last Round

Series A

Jun 3, 2021

Total Funding Raised

$63M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Stablix is a biotechnology company that develops a drug discovery platform focused on targeted protein stabilization to treat rare diseases, cancer, and immunological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

targeted protein stabilizationprotein degradationRestorTACbiotechnologydrug discoveryprotein therapeuticstargeted protein degradationTPDsmall molecule therapeuticsdeubiquitinasechemical biologypreclinical researchbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stablix Comparables

Compare Stablix with similar companies based on industry and business-model similarity.

Stablix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vicinitas Therapeutics
89%
Entact Bio
87%
Atlas Molecular Pharma
79%

Stablix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 3, 2021

Key People

Founding team and executive leadership

Eddine Saiah

Chief Executive Officer

Executive Team

Tony Kingsley

Former CEO

Executive Team

Stablix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 43% MoM, reaching 2.5K.

  • Jun 3, 2021

    $63M round led by Versant Ventures

Stablix Filings

Explore SEC and related filing metadata, where available.

Stablix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stablix's valuation, stock price, and market status.

Is Stablix a public or private company?

Stablix is a private company.

What is the current stock price of Stablix?

Stablix is a private company with no public stock price. No recent secondary market data is available.

How much is Stablix worth (valuation)?

Valuation information for Stablix is not publicly available.

Can I buy Stablix stock?

Stablix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stablix's last funding round?

Stablix's most recent funding round was Series A on June 3, 2021.

Who are the main investors in Stablix?

Key investors in Stablix include Versant Ventures.

Will Stablix IPO soon?

No public IPO plans have been announced for Stablix.

How can I track Stablix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stablix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range12
Year Founded2021
Last FundingJun 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?